OTraces Release: Beyond Liquid Biopsy: Blood Test Can Boost Cancer Detection, Diagnosis With the Tumor Microenvironment (TME), Early Validation Results Reveal (White Paper) Post author:Sam Post published:June 15, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like GlaxoSmithKline to Shift Neuro R&D Out of China to Philadelphia Research Hub August 3, 2017 Opening Of Digital Innovation Lab Underscores Syngenta AG Commitment To Innovation May 16, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017